Globus Medical Inc (NYSE:GMED) currently has a daily average trading volume of 1.56M but it saw 933531 shares traded in last market. With a market cap of 8.02B USD, the company’s current market price of $59.21 came falling about -0.64 while comparing to the previous closing price of $59.59. In past 52 weeks, the stock remained buoying in the range of price level as high as $94.93 and as low as $54.48. In the recent trading on the day, stock has struck highest price mark of $59.12 while lowest mark touched by it was $60.1.
BofA Securities upgraded its recommendation for the stock as a “Neutral” from “Underperform” on January 10, 2025 while assigning a price target of $97. Morgan Stanley issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $83 and $100.
Over the week, GMED’s stock price is moving -3.88% down while it is -18.47% when we observe its performance for the past one month. Year-to-date it is -28.41% down and over the past year, the stock is showing a downside performance of -9.45%.
Currently, Globus Medical Inc’s total number of outstanding shares is 112.93M with 0.69% of that held by the insiders while 100.93% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 4.45% and return on equity (ROE) at 4.63%. It has a price to earnings ratio (P/E ratio) of 44.29 while having a 15.95 of forward P/E ratio. Stock’s beta reads 1.22. Stock has a price to book (P/B) ratio of 1.96 while price to sale or P/S ratio amounts to 3.19. Its return on asset (ROA) is 3.84% on average.
